Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 01:02

    The HD View with Dr. George Yohrling

    in Science

    Tuesday, June 30, 2015 3:30 pm PST/6:30 pm EST


    HDSA's Senior Director, Mission and Scientific Affairs, Dr. George Yohrling will be with us to share information about HDSA's  newly launched HDTrialFinder.org site. Together with HD Drug Works, HD Buzz, HSG, Huntington Society of Canada, and CHDI, Help 4 HD International is proud to partner in this effort to bring education about clinical trials together in one place. It provides precise and strategic information to our HD community about clinical trials that they may qualify for in their area.


    This collaborative effort is a first to bring all the clinical trial information together on one site, a database where information may be called up according to the inquirer's specific location and criteria. Go to: http://hdtrialfinder.org/ and register.


    Other topics of discussion:



    HDSA's 30th Convention
    FDA PDUFA Meeting in September


    Tune in for a very special show with Dr. George Yohrling!

  • 00:01

    Test HD

    in Technology

    Test HD

  • HD with Johnny take 3

    in Technology

    HD with Johnny take 3

  • Testing HD 1

    in Technology

    Testing HD 1

  • 00:02

    Test HD after release

    in Technology

    Test HD after release

  • Testing HD with Johnny V2

    in Technology

    Testing HD with Johnny V2

  • 00:01

    Testing HD

    in Technology

    Testing HD

  • 00:30

    The HD View with Dr. Ottavio Vitolo, MD, MMS

    in Science

    THURSDAY, AUGUST 13, 2015: 6:30 PM EST


    Tonight we have a very special show with Dr. Ottavio V. Vitolo a neuropsychiatrist and Medical Director at Pfizer Inc. He is the Research Project Lead and Global Clinical Lead for the PDE10 in Huntington’s disease program at Pfizer. We will be discussing the new clinical study for Huntington's disease called Amaryllis. Tune in and meet a incredible brillian man Dr. Vitolo.

  • 01:10

    Statement HD

    in Television

    Statement HD is an entertainment hub where unsigned and underground artists can come to showcase their work and gain notoriety. Our focus is promotion and networking, bringing creators together in a place where they can learn, thrive, and succeed. 

  • 00:35

    The HD View Ask Dr. Goodman Show

    in Health

    What is Laqunimod?  Laquinimod is an experimental drug from TEVA Pharmaceuticals that has already been tested in previous clinical trials in several diseases including Multiple Sclerosis (MS).  This drug is thought to affect (or modulate) immune activity by shifting an injurious inflammatory situation to one that is more protective and anti-inflammatory. There is also evidence from various clinical trials that laquinimod may delay progression of disability in MS, and that it reduces brain atrophy as measured by MRI brain scans.  By reducing brain atrophy, this drug may have neuroprotective effects [Varrin-Doyer 2014]. This drug can trigger  protective neuron factors like BDNF (as measured in blood of MS clinical trial participants) that supports the health of neurons.  


    We will be talking about LEGATO-HD clinical research trial that will test the safety of Laquinimod.

  • 00:58

    The HD View Ask Dr. Goodman & Guests

    in Health

    TUESDAY JUNE 2, 2015 - 3:30 pm PST


    Tonight we have a special show with two of Dr. Goodman’s incredible friends who are working directly with the homeless community in Washington State.  As many of you know Huntington’s disease sufferers sometimes end up in homeless situations.  Well, tonight we are going to meet Rev. Jim Bridges who does amazing work to help the homeless and we also get to hear from our super incredible Elizabeth Valenzuela again.  You may remember when she was on the show a year and a half ago when we talked about how she found a man struggling with HD and living in very sad conditions.  We have lots to talk about tonight! Let's get your questions ready for the experts on the state of homlessness.